Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 22 |
NetGPI | no | yes: 0, no: 22 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 3 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: Q4Q3R2
Term | Name | Level | Count |
---|---|---|---|
GO:0000959 | mitochondrial RNA metabolic process | 6 | 3 |
GO:0000963 | mitochondrial RNA processing | 6 | 3 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 3 |
GO:0006396 | RNA processing | 6 | 3 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 3 |
GO:0006807 | nitrogen compound metabolic process | 2 | 3 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0009451 | RNA modification | 5 | 2 |
GO:0009987 | cellular process | 1 | 3 |
GO:0010467 | gene expression | 4 | 3 |
GO:0016070 | RNA metabolic process | 5 | 3 |
GO:0016071 | mRNA metabolic process | 6 | 2 |
GO:0016556 | mRNA modification | 6 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 3 |
GO:0043170 | macromolecule metabolic process | 3 | 3 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 3 |
GO:0044238 | primary metabolic process | 2 | 3 |
GO:0046483 | heterocycle metabolic process | 3 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 3 |
GO:0090304 | nucleic acid metabolic process | 4 | 3 |
GO:0140053 | mitochondrial gene expression | 5 | 3 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 3 |
GO:0003723 | RNA binding | 4 | 3 |
GO:0003729 | mRNA binding | 5 | 3 |
GO:0005488 | binding | 1 | 3 |
GO:0097159 | organic cyclic compound binding | 2 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 329 | 333 | PF00656 | 0.508 |
CLV_C14_Caspase3-7 | 390 | 394 | PF00656 | 0.477 |
CLV_NRD_NRD_1 | 160 | 162 | PF00675 | 0.580 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.707 |
CLV_NRD_NRD_1 | 232 | 234 | PF00675 | 0.472 |
CLV_NRD_NRD_1 | 325 | 327 | PF00675 | 0.427 |
CLV_NRD_NRD_1 | 414 | 416 | PF00675 | 0.337 |
CLV_NRD_NRD_1 | 433 | 435 | PF00675 | 0.489 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.564 |
CLV_PCSK_KEX2_1 | 17 | 19 | PF00082 | 0.705 |
CLV_PCSK_KEX2_1 | 232 | 234 | PF00082 | 0.472 |
CLV_PCSK_KEX2_1 | 325 | 327 | PF00082 | 0.450 |
CLV_PCSK_KEX2_1 | 376 | 378 | PF00082 | 0.373 |
CLV_PCSK_KEX2_1 | 433 | 435 | PF00082 | 0.393 |
CLV_PCSK_PC1ET2_1 | 376 | 378 | PF00082 | 0.421 |
CLV_PCSK_SKI1_1 | 257 | 261 | PF00082 | 0.453 |
CLV_PCSK_SKI1_1 | 376 | 380 | PF00082 | 0.451 |
DOC_MAPK_gen_1 | 160 | 168 | PF00069 | 0.538 |
DOC_MAPK_gen_1 | 266 | 274 | PF00069 | 0.461 |
DOC_MAPK_gen_1 | 433 | 439 | PF00069 | 0.405 |
DOC_MAPK_MEF2A_6 | 358 | 366 | PF00069 | 0.447 |
DOC_MAPK_MEF2A_6 | 420 | 429 | PF00069 | 0.418 |
DOC_PP1_RVXF_1 | 231 | 238 | PF00149 | 0.410 |
DOC_PP1_RVXF_1 | 255 | 261 | PF00149 | 0.472 |
DOC_SPAK_OSR1_1 | 350 | 354 | PF12202 | 0.372 |
DOC_SPAK_OSR1_1 | 365 | 369 | PF12202 | 0.486 |
DOC_USP7_MATH_1 | 100 | 104 | PF00917 | 0.402 |
DOC_USP7_MATH_1 | 207 | 211 | PF00917 | 0.517 |
DOC_USP7_MATH_1 | 291 | 295 | PF00917 | 0.371 |
DOC_USP7_MATH_1 | 316 | 320 | PF00917 | 0.398 |
DOC_USP7_MATH_1 | 498 | 502 | PF00917 | 0.672 |
DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.590 |
DOC_WW_Pin1_4 | 397 | 402 | PF00397 | 0.420 |
DOC_WW_Pin1_4 | 432 | 437 | PF00397 | 0.395 |
LIG_14-3-3_CanoR_1 | 26 | 30 | PF00244 | 0.663 |
LIG_14-3-3_CanoR_1 | 269 | 273 | PF00244 | 0.444 |
LIG_14-3-3_CanoR_1 | 325 | 331 | PF00244 | 0.593 |
LIG_14-3-3_CanoR_1 | 377 | 383 | PF00244 | 0.407 |
LIG_14-3-3_CanoR_1 | 41 | 48 | PF00244 | 0.650 |
LIG_Actin_WH2_2 | 159 | 174 | PF00022 | 0.516 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.561 |
LIG_BRCT_BRCA1_1 | 90 | 94 | PF00533 | 0.485 |
LIG_deltaCOP1_diTrp_1 | 150 | 157 | PF00928 | 0.577 |
LIG_deltaCOP1_diTrp_1 | 236 | 243 | PF00928 | 0.386 |
LIG_deltaCOP1_diTrp_1 | 58 | 64 | PF00928 | 0.451 |
LIG_FHA_1 | 269 | 275 | PF00498 | 0.587 |
LIG_FHA_1 | 31 | 37 | PF00498 | 0.702 |
LIG_FHA_1 | 352 | 358 | PF00498 | 0.481 |
LIG_FHA_1 | 424 | 430 | PF00498 | 0.379 |
LIG_FHA_1 | 433 | 439 | PF00498 | 0.403 |
LIG_FHA_1 | 54 | 60 | PF00498 | 0.570 |
LIG_FHA_1 | 72 | 78 | PF00498 | 0.385 |
LIG_FHA_1 | 91 | 97 | PF00498 | 0.614 |
LIG_FHA_2 | 131 | 137 | PF00498 | 0.611 |
LIG_FHA_2 | 139 | 145 | PF00498 | 0.617 |
LIG_FHA_2 | 197 | 203 | PF00498 | 0.466 |
LIG_GBD_Chelix_1 | 304 | 312 | PF00786 | 0.431 |
LIG_LIR_Gen_1 | 164 | 173 | PF02991 | 0.522 |
LIG_LIR_Gen_1 | 450 | 461 | PF02991 | 0.349 |
LIG_LIR_Gen_1 | 51 | 60 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 164 | 168 | PF02991 | 0.533 |
LIG_LIR_Nem_3 | 175 | 180 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 450 | 456 | PF02991 | 0.350 |
LIG_LIR_Nem_3 | 475 | 479 | PF02991 | 0.467 |
LIG_LIR_Nem_3 | 51 | 55 | PF02991 | 0.440 |
LIG_SH2_CRK | 185 | 189 | PF00017 | 0.419 |
LIG_SH2_CRK | 261 | 265 | PF00017 | 0.465 |
LIG_SH2_CRK | 476 | 480 | PF00017 | 0.467 |
LIG_SH2_SRC | 282 | 285 | PF00017 | 0.416 |
LIG_SH2_SRC | 382 | 385 | PF00017 | 0.382 |
LIG_SH2_STAP1 | 451 | 455 | PF00017 | 0.299 |
LIG_SH2_STAT3 | 79 | 82 | PF00017 | 0.434 |
LIG_SH2_STAT5 | 216 | 219 | PF00017 | 0.479 |
LIG_SH2_STAT5 | 287 | 290 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 356 | 359 | PF00017 | 0.377 |
LIG_SH2_STAT5 | 382 | 385 | PF00017 | 0.552 |
LIG_SH2_STAT5 | 408 | 411 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.435 |
LIG_SH3_1 | 176 | 182 | PF00018 | 0.465 |
LIG_SH3_3 | 176 | 182 | PF00018 | 0.465 |
LIG_SH3_3 | 395 | 401 | PF00018 | 0.440 |
LIG_SH3_3 | 452 | 458 | PF00018 | 0.349 |
LIG_SH3_3 | 92 | 98 | PF00018 | 0.509 |
LIG_SUMO_SIM_anti_2 | 452 | 458 | PF11976 | 0.473 |
LIG_SUMO_SIM_par_1 | 435 | 440 | PF11976 | 0.429 |
LIG_TYR_ITIM | 259 | 264 | PF00017 | 0.440 |
LIG_TYR_ITIM | 449 | 454 | PF00017 | 0.361 |
MOD_CK1_1 | 190 | 196 | PF00069 | 0.453 |
MOD_CK1_1 | 30 | 36 | PF00069 | 0.641 |
MOD_CK1_1 | 394 | 400 | PF00069 | 0.431 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.494 |
MOD_CK1_1 | 71 | 77 | PF00069 | 0.568 |
MOD_CK2_1 | 138 | 144 | PF00069 | 0.700 |
MOD_CK2_1 | 293 | 299 | PF00069 | 0.412 |
MOD_CK2_1 | 70 | 76 | PF00069 | 0.413 |
MOD_CMANNOS | 61 | 64 | PF00535 | 0.395 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.753 |
MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.518 |
MOD_GlcNHglycan | 191 | 195 | PF01048 | 0.546 |
MOD_GlcNHglycan | 293 | 296 | PF01048 | 0.488 |
MOD_GlcNHglycan | 44 | 47 | PF01048 | 0.637 |
MOD_GlcNHglycan | 469 | 472 | PF01048 | 0.397 |
MOD_GSK3_1 | 126 | 133 | PF00069 | 0.747 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.706 |
MOD_GSK3_1 | 316 | 323 | PF00069 | 0.341 |
MOD_GSK3_1 | 387 | 394 | PF00069 | 0.439 |
MOD_GSK3_1 | 490 | 497 | PF00069 | 0.569 |
MOD_GSK3_1 | 71 | 78 | PF00069 | 0.351 |
MOD_N-GLC_1 | 30 | 35 | PF02516 | 0.772 |
MOD_NEK2_1 | 242 | 247 | PF00069 | 0.404 |
MOD_NEK2_1 | 260 | 265 | PF00069 | 0.557 |
MOD_NEK2_1 | 339 | 344 | PF00069 | 0.397 |
MOD_NEK2_1 | 351 | 356 | PF00069 | 0.330 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.738 |
MOD_NEK2_1 | 429 | 434 | PF00069 | 0.378 |
MOD_NEK2_1 | 437 | 442 | PF00069 | 0.456 |
MOD_NEK2_1 | 492 | 497 | PF00069 | 0.523 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.362 |
MOD_NEK2_2 | 320 | 325 | PF00069 | 0.312 |
MOD_PIKK_1 | 356 | 362 | PF00454 | 0.346 |
MOD_PIKK_1 | 418 | 424 | PF00454 | 0.514 |
MOD_PKA_1 | 101 | 107 | PF00069 | 0.572 |
MOD_PKA_1 | 325 | 331 | PF00069 | 0.533 |
MOD_PKA_1 | 376 | 382 | PF00069 | 0.358 |
MOD_PKA_2 | 25 | 31 | PF00069 | 0.706 |
MOD_PKA_2 | 268 | 274 | PF00069 | 0.588 |
MOD_PKA_2 | 324 | 330 | PF00069 | 0.542 |
MOD_PKA_2 | 376 | 382 | PF00069 | 0.453 |
MOD_PKA_2 | 388 | 394 | PF00069 | 0.469 |
MOD_Plk_1 | 138 | 144 | PF00069 | 0.712 |
MOD_Plk_1 | 50 | 56 | PF00069 | 0.475 |
MOD_Plk_1 | 75 | 81 | PF00069 | 0.530 |
MOD_Plk_4 | 101 | 107 | PF00069 | 0.518 |
MOD_Plk_4 | 394 | 400 | PF00069 | 0.413 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.519 |
MOD_Plk_4 | 90 | 96 | PF00069 | 0.613 |
MOD_ProDKin_1 | 397 | 403 | PF00069 | 0.414 |
MOD_ProDKin_1 | 432 | 438 | PF00069 | 0.399 |
TRG_DiLeu_BaLyEn_6 | 433 | 438 | PF01217 | 0.400 |
TRG_ENDOCYTIC_2 | 165 | 168 | PF00928 | 0.586 |
TRG_ENDOCYTIC_2 | 177 | 180 | PF00928 | 0.394 |
TRG_ENDOCYTIC_2 | 185 | 188 | PF00928 | 0.213 |
TRG_ENDOCYTIC_2 | 261 | 264 | PF00928 | 0.441 |
TRG_ENDOCYTIC_2 | 287 | 290 | PF00928 | 0.380 |
TRG_ENDOCYTIC_2 | 451 | 454 | PF00928 | 0.331 |
TRG_ENDOCYTIC_2 | 476 | 479 | PF00928 | 0.469 |
TRG_ER_diArg_1 | 20 | 23 | PF00400 | 0.655 |
TRG_ER_diArg_1 | 231 | 233 | PF00400 | 0.380 |
TRG_ER_diArg_1 | 324 | 326 | PF00400 | 0.397 |
TRG_ER_diArg_1 | 368 | 371 | PF00400 | 0.368 |
TRG_NES_CRM1_1 | 186 | 202 | PF08389 | 0.481 |
TRG_NES_CRM1_1 | 299 | 314 | PF08389 | 0.525 |
TRG_NLS_MonoExtC_3 | 374 | 380 | PF00514 | 0.406 |
TRG_NLS_MonoExtN_4 | 373 | 379 | PF00514 | 0.448 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IK37 | Leptomonas seymouri | 28% | 100% |
A0A0N1IKX3 | Leptomonas seymouri | 81% | 92% |
A0A0S4IN88 | Bodo saltans | 28% | 94% |
A0A0S4JQR1 | Bodo saltans | 55% | 93% |
A0A1X0NRA1 | Trypanosomatidae | 69% | 98% |
A0A1X0NTQ0 | Trypanosomatidae | 29% | 100% |
A0A3Q8II17 | Leishmania donovani | 95% | 100% |
A0A3S7WX47 | Leishmania donovani | 28% | 100% |
A0A422NDT8 | Trypanosoma rangeli | 29% | 100% |
A0A422NKD3 | Trypanosoma rangeli | 67% | 100% |
A4HCA9 | Leishmania braziliensis | 25% | 100% |
A4HLY4 | Leishmania braziliensis | 88% | 100% |
A4HZU2 | Leishmania infantum | 28% | 100% |
A4I9B3 | Leishmania infantum | 95% | 100% |
C9ZJB1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 68% | 100% |
C9ZRN1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9AVP7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9B4B3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
Q4QBT2 | Leishmania major | 28% | 100% |
V5BAI0 | Trypanosoma cruzi | 68% | 100% |
V5BVS4 | Trypanosoma cruzi | 29% | 100% |